Cornerstone Capital Management Holdings’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-33,500
| Closed | -$289K | – | 1415 |
|
|
2016
Q4 | $289K | Buy |
+33,500
| New | +$289K | ﹤0.01% | 1158 |
|
|
2016
Q1 | – | Sell |
-44,500
| Closed | -$273K | – | 1599 |
|
|
2015
Q4 | $273K | Sell |
44,500
-28,000
| -39% | -$172K | ﹤0.01% | 1151 |
|
|
2015
Q3 | $415K | Buy |
72,500
+52,200
| +257% | +$299K | ﹤0.01% | 1063 |
|
|
2015
Q2 | $151K | Sell |
20,300
-400
| -2% | -$2.98K | ﹤0.01% | 1242 |
|
|
2015
Q1 | $124K | Sell |
20,700
-29,800
| -59% | -$179K | ﹤0.01% | 1242 |
|
|
2014
Q4 | $382K | Buy |
+50,500
| New | +$382K | ﹤0.01% | 1009 |
|
|
2014
Q2 | – | Sell |
-3,500
| Closed | -$14K | – | 1441 |
|
|
2014
Q1 | $14K | Buy |
+3,500
| New | +$14K | ﹤0.01% | 1293 |
|
|
2013
Q4 | – | Sell |
-8,600
| Closed | -$43K | – | 1357 |
|
|
2013
Q3 | $43K | Sell |
8,600
-40,800
| -83% | -$204K | ﹤0.01% | 1191 |
|
|
2013
Q2 | $221K | Buy |
+49,400
| New | +$221K | ﹤0.01% | 1038 |
|